Vachon, B. ., Foucault, M. ., Giguère, C. ., Rochette, A. ., Thomas, A. ., & Morel, M. . (1969). Factors Influencing Acceptability and Perceived Impacts of a Mandatory ePortfolio Implemented by an Occupational Therapy Regulatory Organization. The Journal of Continuing Education in the Health Professions, 38(1), 25-31. https://doi.org/10.1097/CEH.0000000000000182 (Original work published 1969)

Foucault, M. ., Vachon, B. ., Thomas, A. ., Rochette, A. ., & Giguère, C. . (2018). Utilisation of an electronic portfolio to engage rehabilitation professionals in continuing professional development: results of a provincial survey. Disability and Rehabilitation, 40(13), 1591-1599. https://doi.org/10.1080/09638288.2017.1300335

Foucault, M. ., , Rosa-Calatrava, M. ., & Riteau, B. . (2011). Role for proteases and HLA-G in the pathogenicity of influenza A viruses. Journal of Clinical Virology : The Official Publication of the Pan American Society for Clinical Virology, 51(3), 155-9. https://doi.org/10.1016/j.jcv.2011.04.013

Foucault, M. ., Depardieu, F. ., Courvalin, P. ., & Grillot-Courvalin, C. . (2010). Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proceedings of the National Academy of Sciences of the United States of America, 107(39), 16964-9. https://doi.org/10.1073/pnas.1006855107 (Original work published 2010)

Foucault, M. ., Thomas, L. ., Goussard, S. ., Branchini, B. ., & Grillot-Courvalin, C. . (2010). In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice. Applied and Environmental Microbiology, 76(1), 264-74. https://doi.org/10.1128/AEM.01686-09

Foucault, M. ., Courvalin, P. ., & Grillot-Courvalin, C. . (2009). Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 53(6), 2354-9. https://doi.org/10.1128/AAC.01702-08

Depardieu, F. ., Foucault, M. ., Bell, J. ., Dubouix, A. ., Guibert, M. ., Lavigne, J. ., … Courvalin, P. . (2009). New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains. Antimicrobial Agents and Chemotherapy, 53(5), 1952-63. https://doi.org/10.1128/AAC.01348-08